Case of pazopanib-induced thyrotoxicosis in a patient with metastatic renal cell carcinoma

Pazopanib is an oral multi-targeted tyrosine kinase inhibitor and has been approved for metastatic renal cell carcinoma and advanced soft tissue sarcoma. To the best of our knowledge, pazopanib-induced thyrotoxicosis has never been reported. The patient was a 68-year-old woman with renal cell carcin...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Int Cancer Conf J
Главные авторы: Kuribayashi, Sohei, Takao, Tetsuya, Okuda, Yohei, Kawamura, Masataka, Nakano, Kosuke, Kishimoto, Nozomu, Takezawa, Kentaro, Tanigawa, Go, Tsutahara, Koichi, Watanabe, Hirotaka, Umayahara, Yutaka, Yamaguchi, Seiji
Формат: Artigo
Язык:Inglês
Опубликовано: Springer Japan 2017
Предметы:
Case Report
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6498272/
https://ncbi.nlm.nih.gov/pubmed/31149484
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13691-017-0288-8
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы